Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.
Saved in:
| Title: | Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials. |
|---|---|
| Authors: | Colombel JF; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Danese S; Department of Gastroenterology, IRCCS San Raffaele Hospital and Vita-Salute University, Milan, Italy., Schreiber S; Department of Medicine I, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Yarur AJ; F. Widjaja Inflammatory Bowel Disease Institute, Cedars Sinai Medical Center, Los Angeles, California, USA., Kang A; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Kim DH; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Lee YN; Global Medical Division, Celltrion Inc., Incheon, Republic of Korea., Hanauer SB; Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. |
| Source: | United European gastroenterology journal [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70205. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2050-6414 |
|---|---|
| DOI: | 10.1002/ueg2.70205 |
